DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Wynn D, Kaufman M, Montalban X , et al; CHOICE investigators.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Lancet Neurol 2010;
9 (4) 381-390
We do not assume any responsibility for the contents of the web pages of other providers.